Malaysian Genomics Resource (0155) — Cash Flow Quality Index
Malaysian Genomics Resource (0155) has a Cash Flow Quality Index of -12.89x as of September 2022. Operating cash flow of RM-10.92 Million is below net income of RM847.00K, suggesting accrual-heavy earnings not yet converted to cash. Also explore Malaysian Genomics Resource total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Malaysian Genomics Resource Cash Flow Quality Index (2015–2022)
Historical Cash Flow Quality Index for Malaysian Genomics Resource across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Malaysian Genomics Resource tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Malaysian Genomics Resource (2015–2022)
Year-by-year earnings quality comparison for Malaysian Genomics Resource. For live market cap and the full company financial profile, see Malaysian Genomics Resource (0155) total market value.
| Year | Quality Index | Operating CF (MYR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | RM56.92K | RM7.21 Million | ▼ -98.8% |
| 2020 | 0.68x | RM11.67 Million | RM17.10 Million | ▼ -87.6% |
| 2017 | 5.50x | RM3.67 Million | RM668.26K | ▲ +160.8% |
| 2016 | 2.11x | RM3.68 Million | RM1.75 Million | ▲ +1833.3% |
| 2015 | 0.11x | RM395.83K | RM3.63 Million | — |